# Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair

Study · id `cardio:ct-nct05421130` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05421130](<https://clinicaltrials.gov/study/NCT05421130>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05421130

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 149 participants.

## Technical summary

Registry record NCT05421130. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-02 (actual); primary completion 2023-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 149 participants (planned count; ClinicalTrials.gov record NCT05421130, source copy `cardio:ctgov-nct05421130-2023-07-11`, retrieved 2026-11-18)
- Started: 2022-05-02 (actual) (ClinicalTrials.gov record NCT05421130, source copy `cardio:ctgov-nct05421130-2023-07-11`, retrieved 2026-11-18)
- Primary completion: 2023-07-01 (anticipated) (ClinicalTrials.gov record NCT05421130, source copy `cardio:ctgov-nct05421130-2023-07-11`, retrieved 2026-11-18)
- Completion: 2024-02-01 (anticipated) (ClinicalTrials.gov record NCT05421130, source copy `cardio:ctgov-nct05421130-2023-07-11`, retrieved 2026-11-18)
- Countries: Germany; Netherlands (ClinicalTrials.gov record NCT05421130, source copy `cardio:ctgov-nct05421130-2023-07-11`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05421130-2023-07-11`, retrieved 2026-11-18)

## The registry's words

- Brief title: Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair
- Condition: Aortic Aneurysm
- Condition: Aortic Dissection
- Condition: Aortic Arch Aneurysm
- Condition: Aortic Arch; Aneurysm, Dissecting
- Intervention (Device): Selective Cerebral Perfusion Catheter
- Lead sponsor: Fuji Systems Corporation
- Lead sponsor class: INDUSTRY
- Collaborator: Avania
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Aortic aneurysm (`cardio:aortic-aneurysm`)
- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry condition terms include this condition: Thoracic aortic aneurysm (`cardio:thoracic-aortic-aneurysm`)
- Registry lists this organization as a collaborator: Avania (`cardio:org-avania`)

## Provenance

Content hash: 79f3ae0325924834f97d1c19e8b7756aa3c4779510b8e860c9159146fec77ae0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
